{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:51Z","timestamp":1791910371957,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Fundacao de Amparo a Pesquisa do Estado de Sao Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129197","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:07:17Z","timestamp":1790932037000},"page":"129197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A multi-antigen chimeric PvCSP\u2013MSP119 vaccine induces robust humoral responses against distinct stages of Plasmodium vivax"],"prefix":"10.1016","volume":"93","author":[{"given":"Laura L.C.L.","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila V.","family":"Maffetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia T.","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo F.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarsila M.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leoneide E.M.","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme A.S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya E.S.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara A.","family":"Gait\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Bargieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia B.","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.V.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Marina","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene S.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129197_bb0005","series-title":"World malaria report 2025: addressing the threat of antimalarial drug resistance","author":"Organization WH","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129197_bb0010","unstructured":"Sistema de Informa\u00e7\u00e3o de Vigil\u00e2ncia Epidemiol\u00f3gica da Mal\u00e1ria (SIVEP-Mal\u00e1ria) [Internet]. 2026."},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2026.129197_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","article-title":"Vivax malaria: neglected and not benign","volume":"77","author":"Price","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129197_bb0020","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4269\/ajtmh.20-0186","article-title":"Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis","volume":"103","author":"Commons","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2026.129197_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-micro-032421-061155","article-title":"Plasmodium vivax latent liver stage infection and relapse: biological insights and new experimental tools","volume":"75","author":"Schafer","year":"2021","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40794-022-00185-3","article-title":"Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication","volume":"8","author":"Habtamu","year":"2022","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129197_bb0035","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129197_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12936-016-1140-x","article-title":"Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon","volume":"15","author":"Peixoto","year":"2016","journal-title":"Malar J"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129197_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004264","article-title":"A library of Plasmodium vivax recombinant merozoite proteins reveals new vaccine candidates and protein-protein interactions","volume":"9","author":"Hostetler","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129197_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161607","article-title":"A comprehensive analysis of plasmodium circumsporozoite protein binding to hepatocytes","volume":"11","author":"Zhao","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1797","article-title":"Unlocking the potential of novel RTS, S\/AS01, and R21\/Matrix-M malaria vaccines in African nations","volume":"7","author":"Oduoye","year":"2024","journal-title":"Health Sci Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2026.129197_bb0060","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/j.vaccine.2012.03.004","article-title":"Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice","volume":"30","author":"Lumsden","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129197_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/IAI.01410-13","article-title":"Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents","volume":"82","author":"Teixeira","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.129197_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/srep46482","article-title":"Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models","volume":"7","author":"Salman","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129197_bb0075","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.vaccine.2024.02.070","article-title":"Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol(R)) as adjuvant","volume":"42","author":"Marques","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129197_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01275","article-title":"Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent malaria parasite","volume":"8","author":"Gimenez","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-19063-6","article-title":"Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb\/Pv sporozoite challenge","volume":"8","author":"de Camargo","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96986-1","article-title":"A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles","volume":"11","author":"Gimenez","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129197_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004423","article-title":"Phase 1\/2a trial of Plasmodium vivax malaria vaccine candidate VMP001\/AS01B in malaria-naive adults: safety, immunogenicity, and efficacy","volume":"10","author":"Bennett","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0100","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41467-022-29226-3","article-title":"Randomized clinical trial to assess the protective efficacy of a plasmodium vivax CS synthetic vaccine","volume":"13","author":"Arevalo-Herrera","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129197_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00126","article-title":"What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?","volume":"8","author":"Lopez","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.129197_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104929","article-title":"Plasmodium vivax vaccine candidate MSP1 displays conserved B-cell epitope despite high genetic diversity","volume":"93","author":"Ghoshal","year":"2021","journal-title":"Infect Genet Evol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2026.129197_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0264-410X(01)00359-0","article-title":"Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors","volume":"20","author":"Cunha","year":"2001","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2026.129197_bb0120","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1016\/j.vaccine.2008.08.070","article-title":"New malaria vaccine candidates based on the Plasmodium vivax merozoite surface protein-1 and the TLR-5 agonist Salmonella typhimurium FliC flagellin","volume":"26","author":"Bargieri","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129197_bb0125","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.micinf.2006.03.012","article-title":"Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)","volume":"8","author":"Rosa","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.129197_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00028","article-title":"Protective immunity in mice immunized with P. vivax MSP1(19)-based formulations and challenged with P. berghei expressing PvMSP1(19)","volume":"11","author":"Dobrescu","year":"2020","journal-title":"Front Immunol"},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129197_bb0135","doi-asserted-by":"crossref","first-page":"W297","DOI":"10.1093\/nar\/gkab408","article-title":"IUPred3: prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation","volume":"49","author":"Erdos","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129197_bb0140","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1110\/ps.062416606","article-title":"Statistical potential for assessment and prediction of protein structures","volume":"15","author":"Shen","year":"2006","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2026.129197_bb0145","series-title":"Genetically-modified sequences encoding plasmodium vivax antigens, vaccine composition containing recombinant purified antigens and recombinant viruses that express those antigens, and prime-boost vaccination protocol against malaria","author":"Bruna Romero","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129197_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8020190","article-title":"Protective malaria vaccine in mice based on the Plasmodium vivax circumsporozoite protein fused with the mumps nucleocapsid protein","volume":"8","author":"Marques","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129197_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1331474","article-title":"Poly I:C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice","volume":"15","author":"Costa-Gouvea","year":"2024","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129197_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167951","article-title":"Safety, immunogenicity and efficacy of prime-boost vaccination with ChAd63 and MVA encoding ME-TRAP against Plasmodium falciparum infection in adults in Senegal","volume":"11","author":"Mensah","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0165","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1038\/s41598-018-21369-y","article-title":"Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model","volume":"8","author":"Yoshida","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.129197_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/srep34527","article-title":"A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP1(19)","volume":"6","author":"Fonseca","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129197_bb0175","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129197_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8060916","article-title":"A multistage formulation based on full-length CSP and AMA-1 ectodomain of Plasmodium vivax induces high antibody titers and T-cells and partially protects mice challenged with a transgenic plasmodium berghei parasite","volume":"8","author":"Lima","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70893-3","article-title":"Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon","volume":"10","author":"Soares","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0190","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1038\/s41598-025-86578-8","article-title":"Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand","volume":"15","author":"Tapaopong","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrm3920","article-title":"Intrinsically disordered proteins in cellular signalling and regulation","volume":"16","author":"Wright","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2026.129197_bb0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59018","article-title":"Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11","volume":"9","author":"Kucharska","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2026.129197_bb0205","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72908","article-title":"Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats","volume":"11","author":"Kucharska","year":"2022","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129197_bb0215","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1073\/pnas.1112648109","article-title":"Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction","volume":"109","author":"Moon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129197_bb0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1172\/JCI70349","article-title":"Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent plasmodium falciparum infection","volume":"124","author":"Foquet","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129197_bb0225","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.129197_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-12-108","article-title":"Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria","volume":"12","author":"Osier","year":"2014","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129197_bb0235","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4049\/jimmunol.1502472","article-title":"Germinal center B cell and T follicular helper cell responses to viral vector and protein-in-adjuvant vaccines","volume":"197","author":"Wang","year":"2016","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:11Z","timestamp":1791908651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"alternative-id":["S0264410X26010066"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129197","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-antigen chimeric PvCSP\u2013MSP119 vaccine induces robust humoral responses against distinct stages of Plasmodium vivax","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129197"}}